When the Watch Beeps: Managing Device-Detected AF
Month: June 2025
Thursday 26th June 2025 / 12:00 - 12:30pm / Online via Zoom
Join us for the upcoming – DaRe2THINK Webinar
This talk is part of a series hosted by the DaRe2THINK trial to provide information to allied healthcare professionals and general practice staff across the UK.
This talk provides a practical update on how wearable devices detect atrial fibrillation (AF), and how to interpret alerts in a clinical context. It offers information on what steps to take when a patient presents with a watch/device-detected AF episode, in the context of the 2024 ESC Guidelines on AF.
Speaker: Dr Emma Svennberg
Dr. Emma Svennberg is an Assistant Professor, Electrophysiologist, and Head of Specialty Training at the Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden. Her primary research interests focus on atrial fibrillation (AF) screening, particularly systematic approaches, where she has played a key role in the large population-based screening studies STROKESTOP I & II.
Dr. Svennberg has been recognized with the Swedish Society of Cardiology Research Award twice and holds fellowships with the European Society of Cardiology (ESC) and the European Heart Rhythm Association (EHRA). She was a founding member and later President of the Swedish branch of Cardiologists of Tomorrow. In 2024, she was elected Treasurer of the EHRA board and currently serves on its Executive Board. She was also part of the ESC 2024 Task Force for the Atrial Fibrillation Guidelines.
DaRe2THINK
This webinar is hosted by DaRe2THINK, a primary care clinical trial sponsored by the NIHR, University of Birmingham and University Hospitals Birmingham NHS Foundation Trust.
DaRe2THINK is a transformational project that will test a new way of running clinical trials at General Practices in the NHS. The trial will use health information already collected in the NHS to reduce the time taken for research, both for the patients and NHS staff. This will allow the NHS to reach new and larger groups of patients that could benefit from new treatments opening the possibility of research to populations that would not have previously taken part.
Webinar schedule:
12:00 – 12:15 – Presentation by Dr Emma Svennberg
12:15 – 12:25 – Q&A and discussion
12:25 – 12:30 – The DaRe2THINK trial
Key benefits:
- Continuing Professional Development
- Learn from academic healthcare professionals (HCPs)
- Be informed of relevant published findings
- Engage in discussions with other HCPs
- Exclusive insight into an ongoing national trial
- Find out how to get involved yourself!
Additional Resources
Hosted by
DaRe2THINK
Nothing found.
Mrs Mary Stanbury
Patient & Public Involvement
Month: June 2025
Patient & Public Involvement
Biography
Mary qualified as a Registered Nurse in 1968 at Queen Elizabeth Hospital and was diagnosed with Atrial Fibrillation (AF) in 2015, this became her reason for becoming a Patient & Public Involvement (PPI) member.
Dr Sarah Wang
Senior Data Science Analyst
Contact:
Email address: Xiaoxia.Wang@uhb.nhs.uk
Month: June 2025
Senior Data Science Analyst
Biography
Sarah Wang is a Senior Data Scientist with the DaRe2THINK team, where she has developed a transparent and robust process for extracting and integrating patient data from routinely collected healthcare datasets. Collaborating closely with the CPRD team, she ensures that clinical trials are powered by accurate and comprehensive information.
With a PhD in Computer Science and Machine Learning, Sarah has dedicated over a decade to working in NHS hospitals, leveraging healthcare data to drive clinical research and quality improvement. Passionate about uncovering insights from complex, large-scale datasets, she is committed to advancing data-driven innovations in healthcare.
Dr Matthew Chapman
Clinical Research Fellow & PhD Student
Contact:
Email address: m.chapman.2@bham.ac.uk
Month: June 2025
Clinical Research Fellow & PhD Student
Biography
Matt Chapman is a clinical research fellow and PhD student. He joined the team in 2024 having previously been working as an Endocrinology & Diabetes specialist trainee.
He is working on the design and implementation of the HYPERMARKER clinical trial which is testing a new approach to drug treatment choice for high blood pressure using pharmacometabolomics (blood tests) and artificial intelligence. This work also involves the integration of public and patient representatives within the study design. He also has a role in participant enrolment of the DaRe2THINK trial and the delivery of the neurovascular sub-study.